Dr. Martens Plc (GB:DOCS)
LSE:DOCS
Want to see GB:DOCS full AI Analyst Report?
DOCS Stock Chart & Stats
69.90 p
-1.05 p(-1.49%)
At close: 4:00 PM EST
69.90 p
-1.05 p(-1.49%)
Day’s Range― - ―
52-Week Range51.30 p - 100.87 p
Previous CloseN/A
Volume189.83K
Average Volume (3M)1.82M
Market Cap
£609.04M
Enterprise Value904.64M
Total Cash (Recent Filing)£95.70M
Total Debt (Recent Filing)£397.10M
Price to Earnings (P/E)―
Beta1.50
Next Earnings
May 28, 2026EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend Yield3.36%
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding967,472,960
10 Day Avg. Volume1,078,739
30 Day Avg. Volume1,820,978
Financial Highlights & Ratios
PEG Ratio-1.17
Price to Book (P/B)1.34
Price to Sales (P/S)0.62
P/FCF Ratio2.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£92.50Price Target Upside32.33% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)0.05
Revenue Forecast (FY)£815.50M
Bulls Say, Bears Say
Bulls Say
Dual-channel Model & Brand StrengthDr. Martens operates a durable dual commercial model—direct-to-consumer plus wholesale—leveraging a strong, iconic brand. DTC gives control over pricing, presentation and higher retail margins while wholesale expands distribution, supporting stable revenue mix and pricing power over multiple cycles.
Strong Free Cash Flow GenerationMaterial free cash flow improvements indicate the business converts sales to cash efficiently, providing durable funding for reinvestment, store/ecommerce growth, and debt paydown. Sustained FCF helps absorb margin volatility and supports strategic investments without relying on external financing.
Debt Reduction And Operating Profit RecoveryYear-on-year net debt reduction and a swing to operating profitability show effective cost control and balance-sheet repair. Lower leverage increases financial flexibility, reduces interest burden, and supports longer-term investment in product, retail and marketing to drive sustainable growth.
Bears Say
Declining Revenue And ProfitabilityMulti-year revenue and profit declines signal structural demand or execution issues beyond short-term cycles. Even with healthy gross margins, eroding net margins compress retained earnings and limit capital for growth initiatives, making recovery dependent on sustained improvements in sales mix and cost structure.
Collapsed Return On EquityA dramatic drop in ROE indicates the company is generating far lower returns on shareholder capital, reducing attractiveness for reinvestment. Persistently weak ROE raises questions about pricing, capital allocation and competitive positioning unless operational improvements sustainably restore profitability.
Regional And Product-segment HeadwindsConcentrated regional weakness (EMEA DTC decline) plus underperformance in core product categories and tariff-driven cost pressure are durable risks. These factors can structurally weigh on revenue mix, increase working capital complexity, and erode margins until product and market issues are resolved.
Dr. Martens Plc News
DOCS FAQ
What was Dr. Martens Plc’s price range in the past 12 months?
Dr. Martens Plc lowest share price was 51.30 p and its highest was 100.87 p in the past 12 months.
What is Dr. Martens Plc’s market cap?
Dr. Martens Plc’s market cap is £609.04M.
When is Dr. Martens Plc’s upcoming earnings report date?
Dr. Martens Plc’s upcoming earnings report date is May 28, 2026 which is in 29 days.
How were Dr. Martens Plc’s earnings last quarter?
Dr. Martens Plc released its earnings results on Nov 20, 2025. The company reported -0.009 p earnings per share for the quarter, the consensus estimate of -0.009 p by 0 p.
Is Dr. Martens Plc overvalued?
According to Wall Street analysts Dr. Martens Plc’s price is currently Undervalued.
Does Dr. Martens Plc pay dividends?
Dr. Martens Plc pays a Semiannually dividend of 0.85 p which represents an annual dividend yield of 3.36%. See more information on Dr. Martens Plc dividends here
What is Dr. Martens Plc’s EPS estimate?
Dr. Martens Plc’s EPS estimate is 0.05.
How many shares outstanding does Dr. Martens Plc have?
Dr. Martens Plc has 967,472,960 shares outstanding.
What happened to Dr. Martens Plc’s price movement after its last earnings report?
Dr. Martens Plc reported an EPS of -0.009 p in its last earnings report, expectations of -0.009 p. Following the earnings report the stock price went down -9.558%.
Which hedge fund is a major shareholder of Dr. Martens Plc?
Currently, no hedge funds are holding shares in GB:DOCS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dr. Martens Plc Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
£92.50 (32.33% Upside)
£92.50 (32.33% Upside)
Insider Transactions
Sold Shares
Worth £133.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
69.81%
12-Months-Change
Fundamentals
Return on Equity
4.40%
Trailing 12-Months
Asset Growth
-7.19%
Trailing 12-Months
Company Description
Dr. Martens Plc
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
DOCS Stock 12 Month Forecast
Average Price Target
92.50 p
▲(32.33% Upside)
Technical Analysis
Options Prices
Currently, No data available
---